CJC-1295 No DAC + Ipamorelin 5/5mg – High-Purity Research Peptide Blend
CJC-1295 No DAC + Ipamorelin 5/5mg – High-Purity Research Peptide Blend
Currently 26 items are in stock!
Couldn't load pickup availability
Lab results
Independent results pending
Independent lab results for CJC-1295 No DAC + Ipamorelin have not been published yet. As soon as the report is issued, we will add it here and to our certificates page, with the lab order number and password so you can verify it yourself.
Need documentation now? Email us and we will send what we hold for your batch.
Request documentationSee published certificates →Product specification
| Compounds | CJC-1295 No DAC (MOD GRF 1-29) + Ipamorelin |
| Contents per vial | 5mg CJC-1295 No DAC + 5mg Ipamorelin (10mg total) |
| Format | Lyophilised (freeze-dried) powder |
| Reconstitution solution | Supplied separately |
| Documentation | COA available on request. Independent results pending |
| Intended use | Laboratory research only. Not for human use. |
About CJC-1295 No DAC + Ipamorelin
A dual-peptide blend combining two well-studied growth hormone secretagogues in a single lyophilised vial, for controlled investigation into growth hormone signalling and endocrine regulation.
CJC-1295 No DAC is a short-acting analogue of growth hormone releasing hormone (GHRH), explored in research for its ability to stimulate pulsatile growth hormone release via GHRH receptor activation. Unlike DAC-modified variants, the No DAC form is designed for shorter-duration signalling.
Ipamorelin is a selective growth hormone secretagogue pentapeptide studied for its ability to stimulate GH release with minimal interaction with other pituitary hormones. It is frequently paired with GHRH analogues in laboratory settings because of its complementary signalling profile.
Handling & reconstitution
Supplied as a lyophilised solid to support long-term stability. Before reconstitution, allow the vial and solvent to reach ambient laboratory temperature. Reconstitute using bacteriostatic water or another suitable solvent in accordance with established research protocols. Avoid repeated freeze–thaw cycles.
Research areas of interest
Preclinical and laboratory investigations have explored this blend across several research pathways:
- Growth hormone signalling: pulsatile GH release and receptor-mediated endocrine signalling.
- Endocrine regulation: pituitary activity and hormonal coordination.
- Metabolic & cellular recovery research: downstream effects on protein synthesis, cellular metabolism and recovery-related pathways.
Research use only
This product is supplied strictly for laboratory research purposes. It is not a medicine, supplement or cosmetic, and is not for human or animal use.
Related research guides
